SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elmer who wrote (1518)5/14/2003 10:08:58 AM
From: scaram(o)uche  Read Replies (2) of 3044
 
Ah, shucks, I get first shot at this easy (ha!) question?

Yes, I do.

But, I don't think that it will look like magic. The trials will be large and expensive, and MLN341 will look like other chemotherapeutics..... modest efficacy with pronounced toxicity.

IMO, it will be another step toward having a cocktail of therapeutics that make chronic diseases of solid cancers. Twenty years..... biotech will have turned solid cancers into "autologous parasites", where the cancers will be occasionally beaten back by selective poisoning, malignancy > patient.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext